This week, Eli Lilly reported that it had brought online LillyPod, a proprietary AI supercomputer that it claims is the strongest in pharma. Lilly says it doesn’t consider the computer IT ...
The 2026 Winter Olympics were defined by a number of factors: the U.S. claiming a record 12 gold medals, the unmatched dominance of Norwegian cross country skier Johannes Høsflot Klæbo and the ...
Ardelyx will leverage the LPGA’s predominantly female audience to directly reach the demographic most affected by IBS-C. The 360-degree approach aims to de-stigmatize chronic gastrointestinal issues ...
This article is part of a Rare Disease series sponsored by DeepIntent. With Rare Disease Month wrapping up and Rare Disease Day taking place on Saturday, MM+M is celebrating a handful of campaigns ...
In a letter that cited ProPublica’s reporting, Sens. Rick Scott and Kirsten Gillibrand asked Secretary Pete Hegseth for more information about the military’s drug supply and its reliance on foreign ...
As U.S. hospitals face an increasing risk of encountering measles, and pressure to immediately spot it, health care workers face an unusual barrier: Many don’t know what it looks like.
Omnicom’s annual report showed its total headcount jumped by more than 45,000, or 60%, to 120,000 at 31 December 2025, after acquiring IPG. That compared with 128,200 that the two companies employed ...
WPP confirmed on Thursday morning that Burson and WPP’s other PR shops will be housed alongside its ad agencies in a new division called WPP Creative as it reported its Q4 and full-year 2025 earnings.
Trump’s proposed ACA plans carry sky-high deductibles; Rare disease advocates fume over the FDA’s mixed signals; Cardiovascular disease on the rise among young women.
In a letter that cited ProPublica’s reporting, Sens. Rick Scott and Kirsten Gillibrand asked Secretary Pete Hegseth for more information about the military’s drug supply and its reliance on foreign ...
The launch of Under Every Hat There’s a Comeback coincides with the release of Nutrafol Men 50+, a hair growth supplement formulated specifically for men over 50. The new product and national campaign ...
Blackstone Life Sciences announced a research and development funding agreement to advance the clinical development of bleximenib, an investigational oral menin inhibitor, for acute myeloid leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results